US Patent 7019193 Treatments using transgenic goat produced antithrombin III
Patent 7019193 was granted and assigned to GTC BIOTHERAPEUTICS, INC. on March, 2006 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 7019193 Treatments using transgenic goat produced antithrombin III
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.